Health care investors in Europe
Updated 16 Nov 2026
Venture funds
38 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Innovate UK Innovate UK runs funding competitions for businesses and research organizations in emerging technologies, with recent awardees including Ryft and Concretene. Swindon, United Kingdom |
Artificial intelligence, Health care | 75% | 10 | |
| 2 | HTGF (High-Tech Gruenderfonds) HTGF invests across various sectors, with recent investments including Rabot Energy and CereGate. Bonn, Germany |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 28% | 5 |
| 3 | Sofinnova Partners Sofinnova Partners invests in life sciences from seed to later stage, including T-Therapeutics, Mironid and DISCO Pharmaceuticals. Paris, France |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 44% | 4 |
| 4 | Amino Collective Amino Collective invests early in health and bio companies, with recent companies including Tandem Health, Rivia and Biomia. Berlin, Germany |
Health care, Biotech | Seed, Early stage venture | 5% | 3 |
| 5 | Ascension Ascension is an early-stage venture firm backing tech and impact founders, with recent companies including Qureight and Greenpixie. London, United Kingdom |
Fintech, Hardware | Seed, Early stage venture | 22% | 3 |
| 6 | Boehringer Ingelheim Venture Fund Boehringer Ingelheim Venture Fund invests in therapeutic approaches and technologies, with recent investments in smartbax and Brainomix. Ingelheim Am Rhein, Germany |
Biotech, Health care | Seed, Early stage venture | 47% | 3 |
| 7 | Global Founders Capital Global Founders Capital supports entrepreneurs at any stage across global markets, with recent investments including Salary Hero and Primo. Berlin, Germany |
Fintech, Commerce | Seed, Early stage venture | 25% | 3 |
| 8 | Novo Holdings Novo Holdings invests in life science companies, with recent companies including Claris Biotherapeutics and Windward Bio. Hellerup, Denmark |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 36% | 3 |
| 9 | Octopus Ventures Octopus Ventures supports companies from idea conception to IPO, including Living Optics and Edgify. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture, Late stage venture | 54% | 3 |
| 10 | Parkwalk Advisors Parkwalk Advisors invests in UK technology companies spun out of universities and research centres, with recent companies including Adsilico and Oxford Quantum Circuits. London, United Kingdom |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 27% | 3 |
| 11 | XTX Ventures XTX Ventures invests in startups applying machine learning, recently backing CloudNC and Qureight. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture | 22% | 3 |
| 12 | BlueYard Capital BlueYard Capital invests in founders with ideas that decentralize markets, with recent investments in Castelion and Cryptio. Berlin, Germany |
Fintech, Biotech | Seed, Early stage venture | 41% | 2 |
| 13 | Cambridge Innovation Capital Cambridge Innovation Capital invests in early-stage deep technology and life sciences companies, including T-Therapeutics and Microbiotica. Cambridge, United Kingdom |
Hardware, Artificial intelligence | Seed, Early stage venture, Late stage venture | 36% | 2 |
| 14 | Creator Fund Creator Fund backs university founders across Europe building at the frontier, including Malted AI, Quantum Diamonds and Helical. London, United Kingdom |
Artificial intelligence, Health care | Seed, Early stage venture | 40% | 2 |
| 15 | Dementia Discovery Fund Dementia Discovery Fund invests exclusively in novel dementia therapeutics, with recent investments in Alchemab Therapeutics and Cerevance. London, United Kingdom |
Biotech, Health care | Seed, Early stage venture | 42% | 2 |
| 16 | Andera Partners Andera Partners makes early- and late-stage venture investments, with recent companies including Kainova Therapeutics and Exciva. Paris, France |
Biotech, Health care | Early stage venture, Late stage venture | 40% | 2 |
| 17 | Eight Roads Ventures Eight Roads Ventures is a global venture firm with offices in the UK, China, India, Japan and the US, recently backing Kaiko and Exponent Energy. London, United Kingdom |
Fintech, Health care | Early stage venture, Late stage venture | 43% | 2 |
| 18 | Elaia Elaia is a full-stack European tech and deep tech investor spanning pre-seed to pre-IPO, with recent backings including Alice & Bob and MyC. Paris, France |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 45% | 2 |
| 19 | Empirical Ventures Empirical Ventures backs unconventional approaches to critical problems in biotechnology and life sciences, with recent companies OSSTEC and Neuronostics. Bristol, United Kingdom |
Health care, Hardware | Seed | 29% | 2 |
| 20 | Eos Eos provides seed funding to ventures based on science, technology and engineering, with recent companies Bioliberty and Neupulse. Saint Andrews, United Kingdom |
Health care, Biotech | Seed, Early stage venture | 54% | 2 |
| 21 | Exceptional Ventures Exceptional Ventures focuses on early-stage entrepreneurs and businesses that improve people's lives, and recently backed Sava Technology and Amatera. London, United Kingdom |
Health care, Biotech | Seed, Early stage venture | 8% | 2 |
| 22 | Forbion Capital Partners Forbion Capital Partners makes private equity and venture capital investments in buyouts, with recent investments in Kynexis and Beacon Therapeutics. Naarden, The Netherlands |
Biotech, Health care | Seed, Early stage venture | 49% | 2 |
| 23 | Future Planet Capital London, United Kingdom |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 3% | 2 |
| 24 | Leaps by Bayer Leaps by Bayer invests in biotechnology, agriculture and scientific breakthroughs, with recent investments in 9amHealth and CORXEL Pharmaceuticals. Leverkusen, Germany |
Health care, Biotech | Early stage venture | 40% | 2 |
| 25 | LUMO labs LUMO Labs is an impact-driven fund investing from pre-seed through Series A, with recent companies including Whispp and AirHub. Eindhoven, The Netherlands |
Artificial intelligence, Health care | Seed, Early stage venture | 72% | 2 |
| 26 | Medicxi Medicxi focuses on life sciences, with recent companies Vaderis Therapeutics and D3 Bio. London, United Kingdom |
Biotech, Health care | Seed, Early stage venture | 54% | 2 |
| 27 | M Ventures M Ventures invests in technologies relevant to Merck's core business areas, with recent investments including Neurable and Quintessent. Amsterdam, The Netherlands |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 37% | 2 |
| 28 | Metaplanet Metaplanet invests across diversified sectors, with recent companies including bit.bio, xCures and Neurable. Tallinn, Estonia |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 13% | 2 |
| 29 | Nextech Invest Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio. Zürich, Switzerland |
Health care, Biotech | Early stage venture, Late stage venture | 31% | 2 |
| 30 | Nina Capital Nina Capital invests in healthcare and technology companies, with recent companies QuantHealth and Rivia. Barcelona, Spain |
Health care, Artificial intelligence | Seed, Early stage venture | 43% | 2 |
| 31 | Nucleus Capital Nucleus Capital backs frontier founders, with recent companies Apoha and Biomia. Berlin, Germany |
Biotech, Health care | Seed, Early stage venture | 32% | 2 |
| 32 | Outsized Ventures Outsized Ventures invests in deep tech companies such as Living Optics and Biorce. London, United Kingdom |
Artificial intelligence, Biotech | Seed, Early stage venture | 23% | 2 |
| 33 | Oxford Science Enterprises Oxford Science Enterprises is a university-partnered firm investing in life science, AI and deep tech, recently backing Fractile and Salience Labs. Oxford, United Kingdom |
Health care, Artificial intelligence | Seed, Early stage venture, Late stage venture | 41% | 2 |
| 34 | SoftBank Vision Fund SoftBank Vision Fund makes growth capital and social impact investments, with recent companies including WHOOP and Opentrons. London, United Kingdom |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 71% | 2 |
| 35 | Speedinvest Speedinvest invests across Pre-Seed, Seed and Series B companies, recently backing Greyparrot and 9amHealth. Vienna, Austria |
Artificial intelligence, Fintech | Seed, Early stage venture, Late stage venture | 41% | 2 |
| 36 | SFC Capital SFC Capital provides diversified exposure to SEIS and EIS businesses through its angel syndicate and seed funds, with recent companies including OSSTEC and Ryft. Northwich, United Kingdom |
Fintech, Artificial intelligence | Seed, Early stage venture | 35% | 2 |
| 37 | Unconventional Ventures Unconventional Ventures is a Nordic early-stage investment firm, with recent companies including Octarine Bio and The Blue Box Biomedical Solutions. Copenhagen, Denmark |
Health care, Biotech | Seed | 53% | 2 |
| 38 | Unilever Ventures Unilever Ventures invests in fast-growing consumer and enterprise technology companies, with recent backings including SkinInspired and Perelel. London, United Kingdom |
Commerce, Health care | Seed, Early stage venture, Late stage venture | 35% | 2 |
Table 1. Health care investors in Europe: venture capital and micro VC funds ranked by health care companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | •••@htgf.de | +49 22••• |
| Venture Kick | Startup incubator | Schlieren, Switzerland | •••@venturekick.ch | +41 (2••• |
| Bpifrance | Government investment office | Maisons-alfort, France | •••@bpifrance.fr | +33 (0••• |
| Innovate UK | Entrepreneurship program | Swindon, United Kingdom | •••@innovateuk.ukri.org | |
| Global Founders Capital | Private equity firm | Berlin, Germany | •••@globalfounderscapital.com | |
| Octopus Ventures | Venture capital firm | London, United Kingdom | •••@octopusvnetures.com | +44 20••• |
| Novo Holdings | Corporate venture arm | Hellerup, Denmark | •••@novo.dk | 45 35 ••• |
| Forbion Capital Partners | Private equity firm | Naarden, The Netherlands | •••@forbion.com | +31 35••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 460 of the 609 health care investors in Europe have a published email address, 336 a phone number and 599 a website.
- HTGF (High-Tech Gruenderfonds) has the most recorded investments, 1,026, 290 of them as lead investor.
- 345 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Innovate UK is an investor in 27 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Durcal's $3.3M Series A on 9 November 2026.
- Software is the most common sector across their 9,418 portfolio companies (75%).
- Early stage venture is the most common investment stage, recorded for 524 of them (86%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Health care investors in Europe
30 of 609, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | Biotech, Health care | Rabot Energy, CereGate, syte | 17 | 1,026 | 290 | 136 | •••@htgf.de | +49 22••• | In the CSV |
| 2 | Venture Kick | Startup incubator | Schlieren, Switzerland | Health care, Biotech | UniSieve, Cotierra, Jaipur Robotics | 13 | 1,459 | 1,342 | 82 | •••@venturekick.ch | +41 (2••• | In the CSV |
| 3 | Bpifrance | Government investment office, Investment bank | Maisons-alfort, France | Artificial intelligence, Hardware | WORMSENSING, CarbonFarm Technology, Archeon | 19 | 1,680 | 454 | 214 | •••@bpifrance.fr | +33 (0••• | In the CSV |
| 4 | Innovate UK | Entrepreneurship program, Venture capital firm | Swindon, United Kingdom | Artificial intelligence, Health care | Bioliberty, Concretene, Doctoria LTD | 27 | 1,307 | 976 | 84 | •••@innovateuk.ukri.org | In the CSV | |
| 5 | European Innovation Council | Startup accelerator | Brussels, Belgium | Hardware, Health care | Onego Bio, Quantrol Ox, Cellbox Solutions | 17 | 1,271 | 921 | 48 | In the CSV | ||
| 6 | Global Founders Capital | Private equity firm, Venture capital firm | Berlin, Germany | Fintech, Commerce | Sirona Medical, Salary Hero, Primo | 19 | 1,027 | 257 | 131 | •••@globalfounderscapital.com | In the CSV | |
| 7 | Octopus Ventures | Venture capital firm | London, United Kingdom | Artificial intelligence, Health care | Living Optics, Metris Energy, Edgify | 9 | 477 | 259 | 73 | •••@octopusvnetures.com | +44 20••• | In the CSV |
| 8 | Novo Holdings | Corporate venture arm, Venture capital firm | Hellerup, Denmark | Health care, Biotech | Claris Biotherapeutics, Windward Bio, Terremoto Biosciences | 5 | 417 | 150 | 115 | •••@novo.dk | 45 35 ••• | In the CSV |
| 9 | Forbion Capital Partners | Private equity firm, Venture capital firm | Naarden, The Netherlands | Biotech, Health care | Kynexis, Beacon Therapeutics | 2 | 188 | 93 | 54 | •••@forbion.com | +31 35••• | In the CSV |
| 10 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | Fintech, Health care | Kaiko, Sonosemi Medical, Exponent Energy | 8 | 552 | 236 | 134 | +91 80••• | In the CSV | |
| 11 | Bayern Kapital | Venture capital firm | Landshut, Germany | Health care, Artificial intelligence | mbiomics, SPiNE, Driveblocks | 4 | 294 | 41 | 41 | •••@bayernkapital.de | +49871••• | In the CSV |
| 12 | KfW | Government investment office, Investment bank | Frankfurt, Germany | Biotech, Health care | CryoTherapeutics, Vectoflow, HelloDuty | 198 | 29 | 56 | •••@kfw.de | 49 69 ••• | In the CSV | |
| 13 | Nina Capital | Micro VC fund, Venture capital firm | Barcelona, Spain | Health care, Artificial intelligence | QuantHealth, Rivia | 2 | 84 | 36 | 5 | •••@nina.capital | In the CSV | |
| 14 | SFC Capital | Angel group, Micro VC fund | Northwich, United Kingdom | Fintech, Artificial intelligence | OSSTEC, Alchera Technologies, Ryft | 11 | 768 | 267 | 23 | •••@sfccapital.com | +44 20••• | In the CSV |
| 15 | Sofinnova Partners | Venture capital firm | Paris, France | Biotech, Health care | T-Therapeutics, Mironid, Bon Vivant | 5 | 373 | 164 | 76 | •••@sofinnovapartners.com | +33 (0••• | In the CSV |
| 16 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | Health care, Biotech | FoRx Therapeutics | 1 | 198 | 74 | 55 | •••@lspvc.com | +31 20••• | In the CSV |
| 17 | Enterprise Ireland | Government investment office | Dublin, Ireland | Artificial intelligence, Hardware | Amethyst Care, CroíValve, Smile Genius Limited | 3 | 955 | 272 | 124 | •••@enterprise-ireland.com | +353 (••• | In the CSV |
| 18 | Novartis Venture Fund | Corporate venture arm, Venture capital firm | Basel, Switzerland | Health care, Biotech | Hepalink, FoRx Therapeutics | 2 | 279 | 75 | 77 | •••@sosei.com | 877 28••• | |
| 19 | Innosuisse | Government investment office | Berne, Switzerland | Health care, Biotech | UniSieve, KEMARO AG, Seprify | 6 | 232 | 184 | 13 | •••@innosuisse.ch | +41 58••• | In the CSV |
| 20 | Verve Ventures | Venture capital firm | Zug, Switzerland | Health care, Artificial intelligence | Stake, Nuclera | 2 | 275 | 37 | 35 | •••@verve.vc | In the CSV | |
| 21 | Bethnal Green Ventures | Startup accelerator | London, United Kingdom | Health care, Fintech | Noggin HQ | 1 | 205 | 36 | 5 | •••@bethnalgreenventures.com | +44 20••• | In the CSV |
| 22 | EIC Accelerator | Startup accelerator | Brussels, Belgium | Health care, Biotech | Millow.co, D-CRBN, Omegga GmbH | 7 | 543 | 517 | 11 | In the CSV | ||
| 23 | Calm/Storm VC | Venture capital firm | Vienna, Austria | Health care, Artificial intelligence | Probably Genetic, PROPCORN AI | 2 | 108 | 9 | 8 | •••@calmstorm.vc | In the CSV | |
| 24 | Partech | Venture capital firm | Paris, France | Hardware, Artificial intelligence | Fresha, OpsMill, Smartness | 5 | 626 | 184 | 117 | •••@partechpartners.com | In the CSV | |
| 25 | Startupbootcamp | Startup accelerator | London, United Kingdom | Fintech, Artificial intelligence | Brickken | 1 | 620 | 58 | 56 | •••@startupbootcamp.org | In the CSV | |
| 26 | Speedinvest | Venture capital firm | Vienna, Austria | Artificial intelligence, Fintech | hexafarms, Nomos, Greyparrot | 6 | 571 | 232 | 56 | •••@speedinvest.com | +43 69••• | In the CSV |
| 27 | Scottish Enterprise | Government investment office | Glasgow, United Kingdom | Health care, Hardware | Bioliberty, Danu Robotics, Mironid | 6 | 392 | 140 | 36 | •••@scotent.co.uk | +03000••• | In the CSV |
| 28 | Kurma Partners | Venture capital firm | Paris, France | Health care, Biotech | Tacalyx | 1 | 131 | 65 | 18 | •••@kurmapartners.com | +33184••• | In the CSV |
| 29 | Hiventures | Venture capital firm | Budapest, Hungary | Health care, Commerce | BOOKR Kids | 1 | 745 | 48 | 7 | •••@hiventures.hu | +36 14••• | In the CSV |
| 30 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program, Government investment office | Lausanne, Switzerland | Health care, Biotech | Adaptyv Biosystems, Carewell, Alithea Genomics | 7 | 345 | 329 | 35 | •••@fondation-fit.ch | +41 21••• | In the CSV |
Table 2. Health care investors in Europe: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 609.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Innovate UK | Swindon, United Kingdom | 27 | 163 | Bioliberty, Concretene, Doctoria LTD |
| 2 | Bpifrance | Maisons-alfort, France | 19 | 344 | WORMSENSING, CarbonFarm Technology, Archeon |
| 3 | Global Founders Capital | Berlin, Germany | 19 | 287 | Sirona Medical, Salary Hero, Primo |
| 4 | European Innovation Council | Brussels, Belgium | 17 | 106 | Onego Bio, Quantrol Ox, Cellbox Solutions |
| 5 | HTGF (High-Tech Gruenderfonds) | Bonn, Germany | 17 | 257 | Rabot Energy, CereGate, syte |
| 6 | Kima Ventures | Paris, France | 16 | 325 | Topo.io, Rayon, Kelvin |
| 7 | Seedcamp | London, United Kingdom | 15 | 203 | Metaview, Flow Engineering, Rayon |
| 8 | Venture Kick | Schlieren, Switzerland | 13 | 129 | UniSieve, Cotierra, Jaipur Robotics |
| 9 | SFC Capital | Northwich, United Kingdom | 11 | 185 | OSSTEC, Alchera Technologies, Ryft |
| 10 | Ascension | London, United Kingdom | 11 | 72 | ManholeMetrics, Qureight, Saltroad |
| 11 | Parkwalk Advisors | London, United Kingdom | 10 | 38 | OSSTEC, Adsilico, Reclinker |
| 12 | Firstminute Capital | London, United Kingdom | 9 | 57 | Mural, Restate, Risk Ledger |
| 13 | Octopus Ventures | London, United Kingdom | 9 | 122 | Living Optics, Metris Energy, Edgify |
| 14 | Picus Capital | Munich, Germany | 8 | 69 | Reflex, Baselayer, FINN |
| 15 | Tiny Supercomputer Investment Company | London, United Kingdom | 8 | 64 | Zero, Neuphonic, bunch |
Table 3. Health care investors in Europe: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Durcal | Durcal makes a mobile app for eldercare. | Hardware | Barcelona, Spain | Series A | $3.3M | 2026-11-09 | $18.8M | Mangrove Capital Partners, K Fund | 11 to 50 | 2013 |
| T-Therapeutics | T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. | Biotech | Cambridge, United Kingdom | Series B | $133.0M | 2026-11-05 | $224.6M | Cambridge Innovation Capital, Sofinnova Partners, University of Cambridge Enterprise | 51 to 100 | 2022 |
| Saidot | Saidot provides a platform that helps organisations manage AI risk, compliance, and policy. | Artificial intelligence | Helsinki, Finland | Seed | $1.8M | 2026-11-05 | $1.8M | Business Finland, Crowberry Capital | 11 to 50 | 2018 |
| bit.bio | Bit.bio provides engineered human cell products and platform services for biomedical research and drug discovery. | Biotech | Cambridge, United Kingdom | Series D | $25.0M | 2026-11-04 | $250.0M | Metaplanet | 101 to 250 | 2016 |
| OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London, United Kingdom | Series A | $8.0M | 2026-11-03 | $12.7M | SFC Capital, Parkwalk Advisors, Embryo Ventures +1 | 11 to 50 | 2021 |
| Zafrens | Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. | Biotech | San Diego, United States | Series A | $6.0M | 2026-11-03 | $35.0M | BlueYard Capital | 11 to 50 | 2022 |
| Bioliberty | Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. | Biotech | Edinburgh, United Kingdom | Series A | $3.3M | 2026-11-02 | $17.4M | Innovate UK, Eos, Scottish Enterprise +2 | 11 to 50 | 2020 |
| Finfra | Finfra enables non-financial platforms to integrate lending and create new revenue streams. | Fintech | Singapore | Series A | $2.5M | 2026-10-30 | $3.5M | Seedstars | 11 to 50 | 2022 |
| Fractile | Fractile develops semiconductor hardware and AI inference systems for large language model processing. | Artificial intelligence | London, United Kingdom | Series C | $771.2M | 2026-10-29 | $1.0B | Oxford Science Enterprises, Kindred Capital | 101 to 250 | 2022 |
| Opentrons Unicorn | Opentrons develops pipetting robots that automate laboratory experiments in the life sciences. | Artificial intelligence | Long Island City, United States | Series E | $40.0M | 2026-10-29 | $300.2M | SoftBank Vision Fund | 251 to 500 | 2014 |
Table 4. Health care investors in Europe: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 7,017 | 75% |
| Artificial intelligence | 2,086 | 22% |
| Fintech | 1,532 | 16% |
| Health care | 1,502 | 16% |
| Hardware | 1,374 | 15% |
| Commerce | 1,033 | 11% |
| Biotech | 726 | 8% |
| Education | 524 | 6% |
| Cybersecurity | 398 | 4% |
| Energy | 257 | 3% |
Table 5. Health care investors in Europe: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 524 | 86% |
| Seed investors | 488 | 80% |
| Venture investors | 262 | 43% |
| Late stage investors | 199 | 33% |
| Private equity investors | 89 | 15% |
| Convertible note investors | 78 | 13% |
| Debt investors | 47 | 8% |
| Grant makers | 45 | 7% |
Table 6. Health care investors in Europe by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Investors | Share |
|---|---|---|
| United Kingdom | 158 | 26% |
| Germany | 106 | 17% |
| Switzerland | 54 | 9% |
| France | 53 | 9% |
| The Netherlands | 34 | 6% |
| Belgium | 25 | 4% |
| Spain | 22 | 4% |
| Sweden | 22 | 4% |
| Italy | 18 | 3% |
| Poland | 16 | 3% |
| Finland | 15 | 2% |
| Denmark | 11 | 2% |
Table 7. Health care investors in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 8. Health care investors in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 64 | 11% |
| 2010s | 290 | 50% |
| 2000s | 119 | 20% |
| 1990s | 60 | 10% |
| 1980s | 21 | 4% |
| 1970s | 8 | 1% |
Table 9. Health care investors in Europe by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded health care companies and its headquarters is in Europe. On 16 November 2026 that is 609 investors.
- 460 rows carry an email address and 336 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 609 rows: 10 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care investors in Europe are on the list?
- 609, in the file dated 16 November 2026. 345 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 460 of the 609 carry an email address in the download and 336 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 609 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $349.
- What arrives after payment?
- At once: the CSV with 609 rows, 460 firm email addresses and 336 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 353 of the 460 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.